Search Results - "Kitamei, Hirokuni"
-
1
Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy
Published in British journal of ophthalmology (01-06-2015)“…To determine predictors of 2-year outcomes after three, monthly, intravitreal ranibizumab (IVR) injections followed by as-needed injections for treatment-naive…”
Get more information
Journal Article -
2
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Published in BMC ophthalmology (16-05-2016)“…To evaluate the quantitative changes of retinal pigment epithelial (RPE) atrophy during 3-year follow-up period of ranibizumab monotherapy for polypoidal…”
Get full text
Journal Article -
3
Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy
Published in British journal of ophthalmology (01-09-2014)“…To determine a correlation between changes in the subfoveal choroidal thickness and outcomes 1 year after ranibizumab therapy for polypoidal choroidal…”
Get more information
Journal Article -
4
Clinical features of intraocular inflammation in Hokkaido, Japan
Published in Acta ophthalmologica (Oxford, England) (01-06-2009)“… Purpose: We aimed to investigate the clinical features of intraocular inflammation/uveitis in Hokkaido, Japan. Methods: We retrospectively reviewed the…”
Get full text
Journal Article -
5
Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration
Published in Japanese journal of ophthalmology (2013)“…Purpose To report the results of triple therapy with photodynamic therapy (PDT) (PDT combined with intravitreal injection of bevacizumab (IVB) and sub-tenon…”
Get full text
Journal Article -
6
Osteopontin Aggravates Experimental Autoimmune Uveoretinitis in Mice
Published in Journal of Immunology (15-05-2007)“…Human endogenous uveitis is a common sight-threatening intraocular inflammatory disease and has been studied extensively using a murine model of experimental…”
Get full text
Journal Article -
7
Comparative Study of Two Sets of Criteria for the Diagnosis of Vogt-Koyanagi-Harada’s Disease
Published in American journal of ophthalmology (01-06-2005)“…The Vogt-Koyanagi-Harada’s (VKH) Disease Committee established the “Revised diagnostic criteria for VKH disease” in 2001. The purpose of the present study was…”
Get full text
Journal Article -
8
Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate
Published in Journal of leukocyte biology (01-06-2006)“…Experimental autoimmune uveoretinitis (EAU) is a T helper type 1 cell‐mediated autoimmune disease, which serves as a model of human chronic uveitis. In this…”
Get full text
Journal Article -
9
The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo
Published in Experimental eye research (01-08-2004)“…Purpose. Ginkgo biloba extract (GBE) contains many different flavone glycosides and terpenoides. Several previous studies have demonstrated that GBE exhibits a…”
Get full text
Journal Article -
10
Chickenpox Chorioretinitis with Retinal Exudates and Periphlebitis
Published in Case reports in ophthalmology (01-05-2012)“…Background: Chickenpox is rarely associated with posterior segment inflammation. We report on a case of unilateral chickenpox chorioretinitis with retinal…”
Get full text
Journal Article -
11
Association of heat shock protein 70 induction and the amelioration of experimental autoimmune uveoretinitis in mice
Published in Immunobiology (1979) (01-01-2007)“…Abstract Experimental autoimmune uveoretinitis (EAU) serves as a model of human endogeneous uveitis. In the present study we examined whether induction of heat…”
Get full text
Journal Article -
12
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR: A Randomized Controlled Trial
Published in Advances in therapy (01-03-2020)“…Purpose To evaluate efficacy and safety of intravitreal injections of aflibercept (IVT-AFL) treat-and-extend (T&E) dosing regimens in treatment-naïve patients…”
Get full text
Journal Article -
13
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
Published in British journal of ophthalmology (01-05-2013)“…To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal…”
Get more information
Journal Article -
14
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
Published in British journal of ophthalmology (01-02-2014)“…To determine the 2-year outcomes of intravitreal bevacizumab (IVB) injections in eyes with macular oedema (ME) following branch retinal vein occlusion (BRVO)…”
Get more information
Journal Article -
15
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup
Published in Advances in therapy (01-06-2022)“…Introduction To explore the efficacy and safety of intravitreal aflibercept (IVT-AFL) proactive, individualized treat-and-extend (T&E) regimens in exudative…”
Get full text
Journal Article -
16
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
Published in Scientific reports (23-08-2017)“…We conducted a genome-wide association study (GWAS) on the outcome of anti-VEGF treatment for exudative age-related macular degeneration (AMD) in a prospective…”
Get full text
Journal Article -
17
Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis
Published in Experimental eye research (01-12-2016)“…Experimental autoimmune uveoretinitis (EAU) represents an experimental model for human endogenous uveitis, which is caused by Th1/Th17 cell-mediated…”
Get full text
Journal Article -
18
Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy
Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2014)“…The purpose of this study was to determine the incidence of vitreous incarceration in sclerotomy after cannula removal during 23-gauge vitrectomy. Thirty-seven…”
Get full text
Journal Article -
19
Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA
Published in Experimental eye research (2010)“…Osteopontin (OPN) is elevated during the progression of experimental autoimmune uveoretinitis (EAU) in C57BL/6 (B6) mice. Furthermore, EAU symptoms are…”
Get full text
Journal Article -
20
Reply
Published in American journal of ophthalmology (01-04-2006)“…[...]big progress has been made in understanding this disease, as well as in examining patients, during the last three decades. [...]the First International…”
Get full text
Journal Article